Journalists are welcome
Time: 9 am-6 pm on Friday 28 May
Venue: Nobel Forum, Nobels väg 1, Karolinska Institutet Solna Campus, Stockholm
Programme: Attached
Caffeine is by far and away the world’s most widespread psychoactive stimulant. At least 70% of the adult population consumes caffeine every day – be it in coffee, tea, energy drinks or other food and drink – in such quantities that it affects the body in some way. The health benefits of caffeine that are now increasingly being supported by research include effects on cognitive ability among the elderly, as well as on Parkinson’s, type 2 diabetes and Alzheimer’s.
New results from population studies and basic research on the effects and mechanisms of caffeine will be presented at the Nobel mini-symposium.
There has been some concern that consuming caffeine during pregnancy can have a negative impact on the unborn child, and that it constitutes a risk factor for cardiovascular disease.
“There are research results that suggest that the children of mothers who consumed caffeine during pregnancy can exhibit behavioural changes, in that they react more strongly than others to substances that stimulate the central nervous system,” says Bertil Fredholm, professor of pharmacology at Karolinska Institutet. “This is thought to be passed on to the following generation.
“But other studies have shown that caffeine can benefit the child as it reduces the risk of temporary pauses in breathing, or apnoeas, in premature babies. It’s important to discuss the pros and cons.”
Many of the leading international researchers in the field will be attending.
For further information, please contact:
Professor Bertil Fredholm, who is responsible for the scientific programme
Tel: +46 8 524 879 39 or +46 70 776 43 44
E-mail: bertil.fredholm@ki.se
Sabina Bossi, press officer
Tel +46 8 524 860 66 or +46 70 614 60 66
E-mail: sabina.bossi@ki.se
Karolinska Institutet is one of the world’s leading medical universities. It accounts for over 40 per cent of the medical academic research conducted in Sweden and offers the country’s broadest range of education in medicine and health sciences. Since 1901 the Nobel Assembly at Karolinska Institutet has selected the Nobel laureates in Physiology or Medicine.
28 February, 2023 - Karolinska Institutet
Following a successful pilot study, an online anonymous treatment program aimed at reducing child sexual abuse by providing treatment to individuals who exhibit sexual urges towards children is being launched across the EU. It is now available in Swedish, German, and Portuguese as well as in an updated English version. The treatment program, which has […]
29 April, 2021 - Karolinska Institutet
Researchers at Karolinska Institutet and the Public Health Agency of Sweden have studied newborn babies whose mothers tested positive for SARS-CoV-2 during pregnancy or childbirth. The results show that although babies born of test-positive mothers are more likely to be born early, extremely few were infected with COVID-19. The study, which is published in the […]
27 April, 2020 - Karolinska Institutet
Only about five per cent of the babies born to mothers with hepatitis C are themselves infected by the disease. A possible reason for this low figure is that the baby’s immune system has already destroyed the virus before birth. A new study from researchers at KI and published in the journal Gut reveals clear […]
7 April, 2020 - Karolinska Institutet
People with celiac disease have increased risk of dying prematurely, despite increased awareness of the disease in recent years and better access to gluten-free food. This is according to a new study from Karolinska Institutet in Sweden and Columbia University in the U.S. published in the prestigious journal JAMA. Celiac disease was linked to increased […]
Expertsvar, The Swedish Research Council, Hantverkargatan 11B, Stockholm SWEDENPhone +46(0)8 546 44 000
P.O. Box 1035, SE-101 38 Stockholm, expertsvar@vr.se
Information about cookies will open in a new window
